Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.20.1
Commitments and Contingencies (Details Narrative)
3 Months Ended
Jan. 10, 2020
USD ($)
Dec. 13, 2019
USD ($)
$ / shares
shares
Aug. 07, 2019
Mar. 31, 2020
USD ($)
Mar. 31, 2020
EUR (€)
Mar. 31, 2019
USD ($)
Mar. 31, 2020
EUR (€)
Dec. 31, 2019
USD ($)
Total Collaborative Agreement Obligations       $ 2,048,180        
Total long-term debt payable       2,675,755        
Total Grants Repayable   $ 335,014      
Common stock, restricted shares issued in exchange of purchased outstanding shares, value 73,263 $ 333,969            
Common stock, restricted shares issued in exchange of purchased outstanding shares, shares | shares   73,263            
Weighted trading price | $ / shares   $ 4.56            
Repayment of debt $ 357,000 $ 350,000            
Holdback period 9 months          
Net liabilities $ 55,404 $ 6,535            
Stock based compensation expense       $ 165,464   $ 338,331    
Operating Lease Right of Use Obligations [Member]                
Weighted average discount rate       4.47%     4.47%  
Weighted average remaining lease term       22 months     22 months  
Operating lease right-of-use assets and liabilities       $ 330,131       $ 338,906
Payment of lease liabilities       62,089        
Operating lease expense       63,035        
Short term lease costs       $ 5,466        
In 2018 [Member] | Finance Lease Obligations [Member] | BNP Paribas leasing solutions [Member]                
Maturity date       Jan. 31, 2022 Jan. 31, 2022      
Amount payable       $ 17,150        
Purchase price for the property | €             € 25,000  
Leased equipment amortized term       5 years 5 years      
May 1, 2019 [Member] | Collaborative Arrangement, Co-promotion [Member]                
Collaborative obligations amount due       $ 224,000        
Research collaboration agreement description       The Company entered into a research collaboration agreement with the University of Taiwan to collect a total of 1,200 samples for a 2-year period for a cost to the Company of up to $320,000 payable over such period. The Company entered into a research collaboration agreement with the University of Taiwan to collect a total of 1,200 samples for a 2-year period for a cost to the Company of up to $320,000 payable over such period.      
In 2015 [Member] | Finance Lease Obligations [Member] | Automated Liquid Handling Robots [Member]                
Maturity date       May 31, 2020 May 31, 2020      
Amount payable       $ 21,155        
Purchase price for the property | €             550,454  
In 2016 [Member] | Finance Lease Obligations [Member] | ING Asset Finance Belgium S.A. [Member]                
Maturity date       Sep. 30, 2024 Sep. 30, 2024      
Amount payable       $ 619,061        
Purchase price for the property | €             1,120,000  
University of Michigan [Member] | In 2017 [Member] | Clinical Study Research Agreement [Member]                
Lease agreement expire period       3 years 3 years      
Collaborative obligations amount       $ 3,000,000        
Collaborative obligations amount due       $ 138,000        
Munich University [Member] | In 2016 [Member] | Collaborative Research Agreement [Member]                
Lease agreement expire period       3 years 3 years      
Collaborative obligations amount | €             360,000  
Collaborative obligations amount due       $ 108,031        
DKFZ [Member] | In 2016 [Member] | Research Co-operation Agreement [Member]                
Lease agreement expire period       5 years 5 years      
Collaborative obligations amount | €             400,000  
Collaborative obligations amount due       $ 220,472        
DKFZ [Member] | In 2015 [Member] | Research Sponsorship Agreement [Member]                
Lease agreement expire period       3 years 3 years      
Collaborative obligations amount | €             338,984  
Collaborative obligations amount due       $ 82,677        
University of Taiwan [Member] | In 2018 [Member] | Clinical Study Research Agreement [Member]                
Lease agreement expire period       3 years 3 years      
Collaborative obligations amount       $ 2,550,000        
Collaborative obligations amount due       1,280,000        
Walloon Region Government [Member] | In 2018 [Member] | Colorectal Cancer Research Agreement [Member]                
Amount payable       $ 200,079        
Grant receivable | €             605,000  
Repayment of grants | €             181,500  
Terms of agreement description       It is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of 181,500 Euros and the 3.53% royalty on revenue, is equal to the amount of funding received. It is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of 181,500 Euros and the 3.53% royalty on revenue, is equal to the amount of funding received.      
Walloon Region Government [Member] | In 2010 [Member]                
Amount payable       $ 134,935        
Grant receivable | €             1,050,000  
Repayment of grants | €             € 314,406  
Terms of agreement description       It is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of 314,406 Euros and the 6% royalty on revenue, is twice the amount of funding received. It is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of 314,406 Euros and the 6% royalty on revenue, is twice the amount of funding received.      
Other income | €         € 733,614      
Long-term Debt [Member] | In 2017 [Member] | Namur Innovation and Growth [Member]                
Fixed interest rate on lease       4.00%     4.00%  
Long-term Debt [Member] | Namur Invest [Member] | In 2017 [Member]                
Fixed interest rate on lease       4.00%     4.00%  
Long-term Debt [Member] | Namur Invest [Member] | In 2016 [Member]                
Fixed interest rate on lease       4.85%     4.85%  
Long-term Debt [Member] | SOFINEX [Member] | In 2017 [Member]                
Fixed interest rate on lease       4.50%     4.50%  
Long-term Debt [Member] | ING [Member] | In 2016 [Member]                
Fixed interest rate on lease       4.80%     4.80%  
Texas A&M University [Member]                
Agreement description       The Company entered into agreement with the Texas A&M University (“TAMU”) System for provision of in kind services of personnel, animal samples and laboratories equipment for a non-controlling interest of 7.5% in Volition Vet and in a year from the agreement TAMU would receive a further 5%, giving them in total 12.5%. The Company entered into agreement with the Texas A&M University (“TAMU”) System for provision of in kind services of personnel, animal samples and laboratories equipment for a non-controlling interest of 7.5% in Volition Vet and in a year from the agreement TAMU would receive a further 5%, giving them in total 12.5%.      
Consulting Services Agreement [Member] | Novis Animal Solutions LLC [Member]                
Potential equity interest     5.00%          
Managing Director's Agreement [Member]                
Transaction agreement description       In connection with the transaction agreement, the Company also entered into a 2-year Managing Director’s agreement with the founder of Octamer for a payment of €288,000 Euros payable in equal monthly installments over such 2-year period and a royalty agreement with the founder providing for the payment of royalties in the amount of 6% of net sales of Octamer’s nucleosomes as reagents to pharmaceutical companies for use in the development, manufacture and screening of molecules for use as therapeutic drugs for a period of 5 years post-closing. In connection with the transaction agreement, the Company also entered into a 2-year Managing Director’s agreement with the founder of Octamer for a payment of €288,000 Euros payable in equal monthly installments over such 2-year period and a royalty agreement with the founder providing for the payment of royalties in the amount of 6% of net sales of Octamer’s nucleosomes as reagents to pharmaceutical companies for use in the development, manufacture and screening of molecules for use as therapeutic drugs for a period of 5 years post-closing.      
Stock based compensation expense       $ 753,000        
Due to related party       277,794        
Loan Agreement [Member] | Long-term Debt [Member] | In 2017 [Member] | Namur Innovation and Growth [Member]                
Total long-term debt payable       $ 551,180        
Repayment of long-term loan amount | €         € 500,000      
Loan agreement term       4 years 4 years      
Loan Agreement [Member] | Long-term Debt [Member] | Namur Invest [Member] | In 2019 [Member]                
Total long-term debt payable       $ 551,180        
Repayment of long-term loan amount | €         € 500,000      
Loan agreement term       4 years 4 years      
Fixed interest rate on lease       4.80%     4.80%  
Maturity date       Sep. 30, 2024 Sep. 30, 2024      
Loan Agreement [Member] | Long-term Debt [Member] | Namur Invest [Member] | In 2017 [Member]                
Total long-term debt payable       $ 153,372        
Repayment of long-term loan amount | €         € 350,000      
Loan agreement term       4 years 4 years      
Loan Agreement [Member] | Long-term Debt [Member] | Namur Invest [Member] | In 2016 [Member]                
Total long-term debt payable       $ 304,298        
Repayment of long-term loan amount | €         € 440,000      
Loan agreement term       7 years 7 years      
Loan Agreement [Member] | Long-term Debt [Member] | SOFINEX [Member] | In 2017 [Member]                
Total long-term debt payable       $ 1,047,242        
Repayment of long-term loan amount | €         € 1,000,000      
Loan agreement term       7 years 7 years      
Loan Agreement [Member] | Long-term Debt [Member] | ING [Member] | In 2016 [Member]                
Total long-term debt payable       $ 243,720        
Repayment of long-term loan amount | €         € 270,000      
Loan agreement term       15 years 15 years